Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway

• मुख्य लेखकों: Feifei Li (लेखक), Youyang Shi (लेखक), Yang Zhang (लेखक), Xiaojuan Yang (लेखक), Yi Wang (लेखक), Kexin Jiang (लेखक), Ciyi Hua (लेखक), Chunyu Wu (लेखक), Chenping Sun (लेखक), Yuenong Qin (लेखक), Sheng Liu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2022-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated. Methods Here, network pharmacology and molecular d...